depression
-
adverse events, antidepressants, British Journal of Psychiatry, clinical trial, depression, difficult-to-treat depression, Editor Eimear Foley, feasibility, major depressive disorder, mdma, MDMA-assisted psychotherapy, open label study, placebo, proof-of-principle, psychedelics, psychotherapy, randomised controlled trial, remission, Safety, Suicidal Ideation, tolerability, topicalMDMA-assisted therapy for depression: a promising but early first step
MDMA was first made in 1912 as an accidental byproduct of a…
-
depression, functional unblinding, MAPS, mdma, MDMA-assisted therapy, Phase 3 trial, psilocybin, psychedelics, PTSD, treatment-resistant depressionPsilocybin for Depression, MDMA for PTSD: What Phase 3 Trials Show
Research Highlights Media coverage of psychedelics is measurably more positive than coverage…
-
Anxiety, bipolar, bmc medicine, child and adolescent, common mental disorders, depression, early intervention, eating disorders, Editor Nina Higson-Sweeney, mental illness prevention, policy, Prevention, psychosis, PTSD, systematic review, topical, umbrella review, youth mental healthA stitch in time: early intervention for young people – promising but patchy evidence
Given that most mental health disorders develop before the age of 25…






